OQS
ACET icon

Occudo Quantitative Strategies’s Adicet Bio ACET Stock Holding History

Occudo Quantitative Strategies’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Buy
16,636
+1,536
+10% +$12.1K 0.01% 712
2026
Q1 		$114K Buy
+15,100
New +$113K 0.01% 703
2024
Q1 		– Sell
-4,767
Closed -$144K – 706
2023
Q4 		$144K Sell
4,767
-304
-6% -$6.63K 0.02% 683
2023
Q3 		$111K Sell
5,071
-3,900
-43% -$138K 0.01% 869
2023
Q2 		$349K Buy
+8,971
New +$792K 0.04% 694

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Occudo Quantitative Strategies's ACET Position: Q2 2026 in Review

Occudo Quantitative Strategies increased its Adicet Bio (ACET) stake by 10% in Q2 2026, buying an estimated $12.1K and bringing the position to 16,636 shares worth $144K. The position accounts for 0.01% of the portfolio, ranked #712.

Occudo Quantitative Strategies first reported a position in ACET in Q2 2023 and has held it in 5 quarters since. The position peaked at $349K in Q2 2023. 56 funds tracked by Wall St. Rank hold ACET as of Q2 2026.

  • Occudo Quantitative Strategies held 16,636 shares of Adicet Bio worth $144K as of Q2 2026.
  • Occudo Quantitative Strategies bought 1,536 Adicet Bio shares in Q2 2026, an estimated $12.1K.
  • Adicet Bio made up 0.01% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #712 holding.
  • Occudo Quantitative Strategies first reported a position in Adicet Bio in Q2 2023 and has held it in 5 quarters since.
  • Occudo Quantitative Strategies's Adicet Bio position peaked at $349K in Q2 2023.
  • 56 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.